Bank Julius Baer & Co
XBI icon

Bank Julius Baer & Co’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bank Julius Baer & Co’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.32M Sell
10,354
-2,352
-19% -$294K ﹤0.01% 360
2025
Q4 		$1.55M Buy
12,706
+2,023
+19% +$232K ﹤0.01% 344
2025
Q3 		$1.07M Sell
10,683
-1,500
-12% -$135K ﹤0.01% 365
2025
Q2 		$1.01M Sell
12,183
-3,500
-22% -$279K ﹤0.01% 336
2025
Q1 		$1.27M Buy
15,683
+2,529
+19% +$226K ﹤0.01% 304
2024
Q4 		$1.31M Buy
13,154
+487
+4% +$47.2K ﹤0.01% 298
2024
Q3 		$1.48M Sell
12,667
-826
-6% -$81.2K 0.01% 268
2024
Q2 		$1.39M Sell
13,493
-38,908
-74% -$3.49M 0.01% 220
2024
Q1 		$4.97M Sell
52,401
-560,889
-91% -$52M 0.02% 199
2023
Q4 		$54.8M Sell
613,290
-14,627
-2% -$1.09M 0.23% 92
2023
Q3 		$45.9M Buy
627,917
+26,728
+4% +$2.13M 0.27% 81
2023
Q2 		$50M Buy
601,189
+6,523
+1% +$546K 0.3% 76
2023
Q1 		$45.3M Sell
594,666
-34,434
-5% -$2.86M 0.29% 83
2022
Q4 		$52.3M Sell
629,100
-11,010
-2% -$891K 0.36% 69
2022
Q3 		$50.8M Sell
640,110
-64,877
-9% -$5.47M 0.39% 65
2022
Q2 		$52.4M Sell
704,987
-62,477
-8% -$4.69M 0.37% 65
2022
Q1 		$69M Buy
767,464
+38,654
+5% +$3.57M 0.41% 55
2021
Q4 		$81.6M Buy
728,810
+165,265
+29% +$19.9M 0.44% 54
2021
Q3 		$70.8M Buy
563,545
+127,688
+29% +$16.4M 0.44% 56
2021
Q2 		$59M Buy
435,857
+74,190
+21% +$9.75M 0.37% 60
2021
Q1 		$49.1M Buy
361,667
+60,396
+20% +$9.04M 0.37% 63
2020
Q4 		$42.4M Buy
301,271
+54,911
+22% +$7.03M 0.35% 60
2020
Q3 		$27.5M Sell
246,360
-36,224
-13% -$4.06M 0.27% 76
2020
Q2 		$31.4M Sell
282,584
-35,610
-11% -$3.51M 0.36% 62
2020
Q1 		$21.2M Buy
+318,194
New +$28.2M 0.49% 58

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank Julius Baer & Co's XBI Position: Q1 2026 in Review

Bank Julius Baer & Co reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 19% in Q1 2026, selling an estimated $294K and leaving 10,354 shares worth $1.32M. The position accounts for ﹤0.01% of the portfolio, ranked #360.

Bank Julius Baer & Co first reported a position in XBI in Q1 2020 and has held it in 25 quarters since. The position peaked at $81.6M in Q4 2021. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • Bank Julius Baer & Co held 10,354 shares of State Street SPDR S&P Biotech ETF worth $1.32M as of Q1 2026.
  • Bank Julius Baer & Co sold 2,352 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $294K.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Bank Julius Baer & Co's portfolio in Q1 2026, its #360 holding.
  • Bank Julius Baer & Co first reported a position in State Street SPDR S&P Biotech ETF in Q1 2020 and has held it in 25 quarters since.
  • Bank Julius Baer & Co's State Street SPDR S&P Biotech ETF position peaked at $81.6M in Q4 2021.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on Bank Julius Baer & Co's 13F filing for Q1 2026, filed 5 May 2026.